JOSÉ
HERNÁNDEZ QUERO
Investigador desde 2023
LEOPOLDO
MUÑOZ MEDINA
Investigador en el periodo 2022-2023
Publicaciones en las que colabora con LEOPOLDO MUÑOZ MEDINA (30)
2022
-
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
JHEP Reports, Vol. 4, Núm. 5
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Empirical treatment with doxycycline of fever of intermediate duration
European Journal of Clinical Microbiology and Infectious Diseases
-
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Journal of Biomedical Science, Vol. 28, Núm. 1
-
Hemophagocytic lymphohistiocytosis associated with Leishmania: A hidden passenger in endemic areas
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 4, pp. 188-191
2020
-
Imported babesiosis caused by Babesia microti—A case report
Ticks and Tick-borne Diseases
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2018
2017
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2016
-
Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics
Open Forum Infectious Diseases, Vol. 3, Núm. 2
2015
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
-
Nebulized medication is not associated with nosocomial infections. A pilot study
Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 154-156
-
Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis
Infection, Vol. 43, Núm. 5, pp. 531-535
2014
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Letter: Accuracy of liver stiffness measurement - A comparison of two different FibroScan devices
Alimentary Pharmacology and Therapeutics
-
Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes
AIDS, Vol. 28, Núm. 12, pp. 1835-1837
2009
-
Bacteriemia persistente por Staphylococcus aureus resistente a meticilina. El resultado de un tratamiento inadecuado
Enfermedades Infecciosas y Microbiologia Clinica
-
Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to HAART and impact of mortality
Current HIV Research, Vol. 7, Núm. 2, pp. 224-230